Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sirolimus (Rapamune®)
DRUG
3 trials
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
, Peking Union Medical College Hospital
, Ain Shams University
Conditions
Aplastic Anaemia
Orbital Lymphatic Malformation
Renal Transplant
Phase 2
Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A
Recruiting
NCT06802055
Peking Union Medical College Hospital
Aplastic Anaemia
Start: 2025-01-25
End: 2027-01-31
Target: 40
Updated: 2025-06-04
Phase 3
Study Evaluating Rapamune® Maintenance Regimen
Completed
NCT00478608
Wyeth is now a wholly owned subsidiary of Pfizer
Renal Transplant
Start: 2007-03-31
End: 2008-11-30
Updated: 2010-04-28
Systematic Approach for Children With Orbital Malformation With Sirolimus Use
Recruiting
NCT07378657
Ain Shams University
Orbital Lymphatic Malformation
Start: 2025-11-01
End: 2027-11-01
Target: 30
Updated: 2026-01-30